Chemoradiation in cancer therapy
著者
書誌事項
Chemoradiation in cancer therapy
(Cancer drug discovery and development)
Humana Press, 2003
大学図書館所蔵 全5件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Internationally recognized experts in cancer biology and clinical research review the present status of the multimodality approach to the management of solid tumors and speculate on possible future strategies for chemoradiation therapy. The authors detail applications of combined modality therapy in lung, esophageal, breast, gastric, pancreatic, colon, and rectal cancers. They also show how radiation interacts with such chemotherapeutic agents as the platinum complexes, taxanes, and gemcitabine in the treatment of malignant gliomas, and head and neck cancer. A review of how to integrate new specific molecular targeted agents into multimodality therapy in the future.
目次
Part I. General/Background
Chemoradiation: Biological Principles and Perspectives
Hak Choy and Robert M. MacRae
Fluoropyrimidines as Radiation Sensitizers
Muhammad Wasif Saif and Robert B. Diasio
Part II. Mechanisms of Interaction of Specific Chemotherapeutic Agents with Radiation
The Role of Platinum Complexes in Combined Modality Therapy
Beverly A. Teicher
Taxanes in Combined Modality Therapy
Robert M. MacRae and Hak Choy
Camptothecin Radiation Sensitization
Tyvin A. Rich
The Role of Gemcitabine in Combined Modality Therapy
Jerome Landry, William Blackstock, Robert M. MacRae, Gary Yang, and Hak Choy
Part III. Clinical Applications
Chemoradiation Strategies for Patients with Malignant Gliomas
Heather A. Curry and Walter J. Curran, Jr.
Combined Modality Strategies in the Treatment of Head and Neck Cancer
Cathy Eng and Everett E. Vokes
The Role of Combined Modality Therapy for Stage III Nonsmall-Cell Lung Cancer
Roger W. Byhardt
Combined Modality Treatment of Small-Cell Lung Cancer
Julie R. Brahmer, Larry Kleinberg, and David S. Ettinger
The Role of Chemoradiation in the Management of Esophageal Cancer
Arlene Forastiere and Bapsi Chak
Combined Modality Therapy in Locally Advanced Breast Cancer
Silvia C. Formenti and Matthew Volm
Combined Modality Therapy for Gastric, Pancreatic, and Biliary Tract Carcinomas
Alexandria Phan and Jaffer A. Ajani
Chemoradiation in Therapy for Colon and Rectum Carcinoma
Jason H. Lee and Christopher G. Willett
Chemoradiotherapy in Muscle-Invasive Bladder Cancer
Bruce J. Roth
The Role of Combined Chemotherapy and Radiation Therapy in the Treatment of Gynecologic Malignancies
Patricia J. Eifel
Part IV. Specific Molecular Targeted Agents
Overview of Specific Molecular Targeted Agents for Combined Modality Therapy
Scott Saxman and Janet Dancey
Receptor Tyrosine Kinases as Therapeutic Targets in Solid Tumors
Stacy L. Moulder and Carlos L. Arteaga
Adenoviral p53 Gene Therapy Strategies in Nonsmall-Cell Lung Cancer
Stephen G. Swisher and Jack A. Roth
Tumor Microvasculature as a Therapeutic Target During Radiotherapy
Dennis E. Hallahan and Don Stacy
Cancer Drug Discovery and Development: Maximizing the Therapeutic Potential of Matrix Metalloproteinase Inhibitors for the Treatment of Cancer
Jeffrey S. Humphrey, Karen Price, Elora Gupta, Andrew Baxter, John Bird, Daryl Sonnichsen, and Joseph Naglich
The Role of Cyclooxygenase-2 Inhibitors in Combined Modality Therapy
Hong Pyo, Raymond N. DuBois, and Hak Choy
Index
「Nielsen BookData」 より